Patents by Inventor Theresa E. Latham

Theresa E. Latham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant isfahan viral vectors
    Patent number: 9932564
    Abstract: Certain embodiments are directed to recombinant vesiculovirus encoding a heterologous polynucleotide and methods of using the same.
    Type: Grant
    Filed: February 27, 2015
    Date of Patent: April 3, 2018
    Assignees: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM, PROFECTUS BIOSCIENCES, INC.
    Inventors: Demetrius Matassov, Rodion V. Gorchakov, Stefan Hamm, Rebecca Nowak, Robert L. Seymour, John H. Eldridge, Robert B. Tesh, David K. Clarke, Theresa E. Latham, Scott Weaver, Farooq Nasar
  • RECOMBINANT ISFAHAN VIRAL VECTORS
    Publication number: 20170067027
    Abstract: Certain embodiments are directed to recombinant vesiculovirus encoding a heterologous polynucleotide and methods of using the same.
    Type: Application
    Filed: February 27, 2015
    Publication date: March 9, 2017
    Inventors: Demetrius Matassov, Rodion V. Gorchakov, Stefan Hamm, Rebecca Nowak, Robert L. Seymour, John H. Eldridge, Robert B. Tesh, David K. Clarke, Theresa E. Latham, Scott Weaver
  • Assembly of wild-type and chimeric influenza virus-like particles (VLPs)
    Patent number: 8859231
    Abstract: Influenza virus-like particles (VLPs) comprising the structural proteins HA, NA, M1 and M2 are described. VLPs are also generated containing M1 alone, as are VLPs with M1 and any one or two of HA, NA and M2. VLPs with HA from one influenza subtype and NA from a different influenza subtype are also described, as are VLPs in which a portion or all of HA or NA is replaced by a heterologous moiety not produced by influenza virus, so as to comprise chimeric VLPs.
    Type: Grant
    Filed: June 2, 2009
    Date of Patent: October 14, 2014
    Assignee: Wyeth LLC
    Inventors: Jose M. Galarza, Theresa E. Latham
  • ASSEMBLY OF WILD-TYPE AND CHIMERIC INFLUENZA VIRUS-LIKE PARTICLES (VLPs)
    Publication number: 20090239261
    Abstract: Influenza virus-like particles (VLPs) comprising the structural proteins HA, NA, M1 and M2 are described. VLPs are also generated containing M1 alone, as are VLPs with M1 and any one or two of HA, NA and M2. VLPs with HA from one influenza subtype and NA from a different influenza subtype are also described, as are VLPs in which a portion or all of HA or NA is replaced by a heterologous moiety not produced by influenza virus, so as to comprise chimeric VLPs.
    Type: Application
    Filed: June 2, 2009
    Publication date: September 24, 2009
    Applicant: WYETH HOLDINGS CORPORATION
    Inventors: JOSE M. GALARZA, THERESA E. LATHAM
  • Assembly of wild-type and chimeric influenza virus-like particles (VLPs)
    Patent number: 7556940
    Abstract: Influenza virus-like particles (VLPs) comprising the structural proteins HA, NA, M1 and M2 are described. VLPs are also generated containing M1 alone, as are VLPs with M1 and any one or two of HA, NA and M2. VLPs with HA from one influenza subtype and NA from a different influenza subtype are also described, as are VLPs in which a portion or all of HA or NA is replaced by a heterologous moiety not produced by influenza virus, so as to comprise chimeric VLPs.
    Type: Grant
    Filed: March 28, 2005
    Date of Patent: July 7, 2009
    Assignee: Wyeth Holdings Corporation
    Inventors: Jose M. Galarza, Theresa E. Latham